✦ LIBER ✦

P-299 Azacitidine in high-risk MDS patients. A “real life” experience from a single center

✍ Scribed by Greco, R.; Riva, M.; Ravano, E.; Molteni, A.; Morra, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-288 Azacitidine therapy in high-risk m

✍ Improta, S.; Gagliardi, A.; Villa, M.R.; Cioppa, P. Della; Esposito, M.; Izzo, G 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Azacitidine has limited activity in ‘rea

✍ Murat Ozbalak; Mustafa Cetiner; Huseyin Bekoz; Elif Birtas Atesoglu; Cem Ar; Ays 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

O-020 Erythropoietin alpha therapy in 11

✍ Messa, E.; Gioia, D.; Masiera, E.; Allione, B.; Balleari, E.; Bonferroni, M.; Ca 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Endovascular Stent Graft Repair of Abdom

✍ SUHAIL ALLAQABAND; MOHAMMAD E. MORTADA; RAMAGOPAL TUMULURI; ASHOK KUMAR; TANVIR 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB

170-P A single center experience in tran

✍ Adam Schoen; Nebila Abdulwahab; Nicholas Dipaola 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 34 KB

Mid-term results of TAVI in high-risk pa

✍ Akchurin, R; Imaev, T; Lepilin, P; Kolegaev, A; Komlev, A; Pokidkin, I 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 250 KB